Correspondence: A Letter to Editor Regarding Evaluation of the Prescription Pattern of Drugs used in the Treatment of Pelvic Inflammatory Disease at a Tertiary Care Hospital in Pune: A Cross-sectional Study

Dear Editor, The authors of this letter recently reviewed the article titled “Evaluation of the Prescription Pattern of Drugs Used in Treatment of Pelvic Inflammatory Disease at a Tertiary Care Hospital in Pune: A Cross-sectional Study,” published on November 1, 2025, in the Journal of Clinical and Diagnostic Research (JCDR) [1]. Standard Drug-utilisation Study (DUS) parameters—such as the average number of drugs per prescription, the proportion of generic versus brand prescribing, the percentage of drugs prescribed from the essential medicines list, the proportion of antibiotic combinations and adherence to recommended Pelvic Inflammatory Disease (PID) treatment regimens—have not been reported [2]. This represents a major limitation of the study, as these indicators are fundamental to drug-utilisation research. Furthermore, the discussion section largely reiterates descriptive findings without providing in-depth analysis. There is no exploration of the possible reasons behind the observed prescribing trends, no comparison with standard treatment guidelines and no discussion of the clinical implications of these findings. The authors’ response could not be obtained for inclusion in this letter to the editor.